Cambridge Cognition, C2N Diagnostics, Alzheimer's Trust partner for UK dementia diagnosis
Cambridge Cognition, C2N Diagnostics and The Alzheimer's Trust have partnered to create an integrated pathway for earlier and more accurate diagnosis of Alzheimer's disease and related dementias in the UK. The collaboration includes C2N's PrecivityAD2 test and Cambridge Cognition's CANTAB Pathway cognitive assessment p